INTERACTION BETWEEN DIGOXIN AND PROPAFENONE IN CHILDREN

被引：9

作者：

ZALZSTEIN, E

KOREN, G

BRYSON, SM

FREEDOM, RM

机构：

[1] HOSP SICK CHILDREN, DEPT PEDIAT, DIV CLIN PHARMACOL, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA

[2] HOSP SICK CHILDREN, RES INST, DIV CARDIOL, TORONTO M5G 1X8, ONTARIO, CANADA

[3] HOSP SICK CHILDREN, THERAPEUT DRUG MONITORING SERV, TORONTO M5G 1X8, ONTARIO, CANADA

来源：

JOURNAL OF PEDIATRICS | 1990年 / 116卷 / 02期

关键词：

D O I：

10.1016/S0022-3476(05)82900-2

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

[No abstract available]

引用

页码：310 / 312

页数：3

共 9 条

[1] INTERACTION BETWEEN DIGOXIN AND CALCIUM-ANTAGONISTS AND ANTI-ARRHYTHMIC DRUGS [J].

BELZ, GG ;

DOERING, W ;

MUNKES, R ;

MATTHEWS, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (04) :410-417

[2] INTERACTION BETWEEN DIGOXIN AND PROPAFENONE [J].

CALVO, MV ;

MARTINSUAREZ, A ;

LUENGO, CM ;

AVILA, C ;

CASCON, M ;

HURLE, AD .

THERAPEUTIC DRUG MONITORING, 1989, 11 (01) :10-15

[3] CLINICAL EFFICACY AND ELECTROPHYSIOLOGY OF ORAL PROPAFENONE FOR VENTRICULAR-TACHYCARDIA [J].

CONNOLLY, SJ ;

KATES, RE ;

LEBSACK, CS ;

ECHT, DS ;

MASON, JW ;

WINKLE, RA .

AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (10) :1208-1213

[4] QUINIDINE-DIGOXIN INTERACTION - PHARMACOKINETICS, UNDERLYING MECHANISM AND CLINICAL IMPLICATIONS [J].

DOERING, W .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (08) :400-404

[5]

HOFFMAN DH, 1974, CLIN PHARMACOL THER, V16, P310

[6]

KOREN G, 1988, J PHARMACOL EXP THER, V247, P1193

[7] DIGOXIN TOXICITY ASSOCIATED WITH AMIODARONE THERAPY IN CHILDREN [J].

KOREN, G ;

HESSLEIN, PS ;

MACLEOD, SM .

JOURNAL OF PEDIATRICS, 1984, 104 (03) :467-470

[8]

KOREN G, 1985, PEDIATRICS, V75, P1032

[9] A CONTROLLED TRIAL OF PROPAFENONE FOR TREATMENT OF FREQUENT AND REPETITIVE VENTRICULAR PREMATURE COMPLEXES [J].

SALERNO, DM ;

GRANRUD, G ;

SHARKEY, P ;

ASINGER, R ;

HODGES, M .

AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (01) :77-83

← 1 →